Proliferation of subconjunctival fibroblasts plays a critical role in scarring and failure of glaucoma filtering surgery. Long-term topical glaucoma medications appear to increase fibroblast proliferation. In this study, the effects of topical antiglaucoma drugs latanoprost and GLC756, a novel dopamine D2 agonist and D1 antagonist, on cultured normal human dermal fibroblasts (NHDF) were examined.
Methods
The NHDF cell line was incubated with latanoprost, prostaglandinF2α (PGF2α), GLC756, or 5-fluorouracil as a positive control at concentrations of 3 and 30 μM for 6, 18, and 24 hours. Fibroblast growth was measured by 5-bromodeoxyuridine (BrdU) uptake using laser scanning cytometry.
Results
Latanoprost and PGF2α had a biphasic response on the number of cultured NHDF positively stained with BrdU. A stimulating effect on proliferation occurred early, 6 hours after incubation, and an inhibitory effect 18 to 24 hours after incubation. GLC756, in contrast, revealed only inhibitory effects on BrdU uptake 18 to 24 hours after incubation. The pattern of GLC756 was similar to that of the positive control 5-fluorouracil.
Conclusions
Latanoprost seemed to have a biphasic response on the proliferation of cultured NHDF. First there was a stimulating thereafter a secondary negative modulating effect. GLC756 had a fully antiproliferative effect on the NHDF, indicating an additional potential of novel dopamine compounds for topical glaucoma medication.
ZiaiN., DolanJ.W., KacereR.D., BrubakerR.F.The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes.Arch Ophthalmol1993; 111: 1351–8.
2.
AimA., StjernschantzJ.Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.Ophthalmology1995; 102: 1743–52.
3.
PrünteC., FlammerJ.The novel dopamine D1 antagonist and D2 agonist, SDZ GLC 756, lowers intraocular pressure in healthy human volunteers and in patients with glaucoma.Ophthalmology1995; 102: 1291–7.
4.
PrünteC., FlammerJ., MarksteinR., RudinM.Quantification of optic nerve blood flow using MR-imaging.Invest Ophthalmol Vis Sci1995; 36: 247–51.
5.
ChiouG.C., ChenY.J.Effects of dopamine agonist, bromocriptine, and some dopamine antagonists on ocular blood flow.J Ocul Pharmacol1992; 8: 285–94.
6.
MarksteinR., GullP., RudebergC.SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors.J Neural Transm1996; 103: 17–30.
7.
PrünteC., NuttliI., MarksteinR.Topical SDZ GLC-756, a novel dopamine D-1 antagonist and D-2 agonist, lowers intraocular pressure in conscious rabbits.Jpn J Ophthalmol1996; 40: 167–73.
8.
SherwoodM.B., GriersonI., MillarL., HitchingsR.A.Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients.Ophthalmology1989; 96: 327–35.
9.
MaumeneeA.E.External filtering operations for glaucoma: the mechanism of function and failure.Trans Am Ophthalmol Soc1960; 58: 319–28.
10.
FlaxelJ.T., SwanK.C.Limbal wound healing after cataract extraction.Arch Ophthalmol1969; 81: 653–9.
11.
MillerM.H., GriersonI., LingerW.I., HitchingsR.A.Wound healing in an animal model of glaucoma fistulizing surgery in the rabbit.Ophthalmic Surg1989; 20: 350–7.
12.
AddicksE.M., QuigleyH.A., GreeneW.R., RobinA.L.Histologic characteristics of filtering blebs in glaucomatous eyes.Arch Ophthalmol1983; 101: 795–8.
13.
BroadwayD.C., GriersonI., O'BrienC., HitchingsR.A.Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery.Arch Ophthalmol1994; 112: 1446–53.
14.
LavinM.J., WormaldRR, MigdalC.S., HitchingsR.A.The influence of priortherapy on the success of trabeculectomy.Arch Ophthalmol1990; 108: 1543–8.
15.
YoungT.L., HigginbothamE.J., ZouX.L., FarberM.D.Effects of topical glaucoma drugs on fistulized rabbit conjunctiva.Ophthalmology1990; 97: 1423–7.
16.
LarkK.K., PashaA.S., YanX., EdwardD.P.The effect of latanoprost and brimonidine on rabbit subconjunctival fibroblasts.J Glaucoma1999; 8: 72–6.
17.
WilliamsD.E., NguyenK.D., Shapourifar-TehraniS., KitadaS., LeeD.A.Effects of timolol, betaxolol, and levobunolol on human Tenon's fibroblasts in tissue culture.Invest Ophthalmol Vis Sci1992; 33: 2233–41.
18.
CunliffeI.A., McIntyreC.A., ReesR.C., RennieI.G.The effect of topical cholinergic medications on human Tenon's capsule fibroblasts in tissue culture.Graefes Arch Clin Exp Ophthalmol1995; 233: 507–12.
19.
CunliffeI.A., McIntyreC.A., ReesR.C., RennieI.G.Pilot study on the effect of topical adrenergic medications on human Tenon's capsule fibroblasts in tissue culture.Br J Ophthalmol1995; 79: 70–5.
20.
WuK.Y., HongS.J., WangH.Z.Effects of pilocarpine and other antiglaucoma drugs on cultured human Tenon's fibroblast cells.J Ocul Pharmacol Ther1997; 13: 13–20.
21.
WuK.Y., HongS.J., ChungY.M.Effects of dopamine antagonists and agonist on cultured human Tenon's fibroblast cells.Kaohsiung J Med Sci1996; 12: 388–93.
AriturkN., OgeI., BarisS., ErkanD., SulluY., KocF.The effects of antiglaucomatous agents on conjunctiva used for various durations.Int Ophthalmol1997; 20: 57–62.
24.
BroadwayD.C., GriersonI., O'BrienC., HitchingsR.A.Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile.Arch Ophthalmol1994; 112: 1437–45.
25.
KellettM., PottenC.S., RewD.A.A comparison of in vivo cell proliferation measurements in the intestine of mouse and man.Epithelial Cell Biol1992; 1: 147–55.
26.
HeuerD.K., ParrishR.K., GresselM.G., HodappE., PalmbergP.F., AndersonD.R.5-fluorouracil and glaucoma filtering surgery. II. A pilot study.Ophthalmology1984; 91: 384–94.
27.
RockwoodE.J., ParrishR.K., HeuerD.K.Glaucoma filtering surgery with 5-fluorouracil.Ophthalmology1987; 94: 1071–8.
28.
DurantS., DuvalD., Homo-DelarcheF.Effect of exogenous prostaglandins and nonsteroidal anti-inflammatory agents on prostaglandin secretion and proliferation of mouse embryo fibroblasts in culture.Prostaglandins Leukotrienes Essential Fatty Acids1989; 38: 1–8.
29.
De AsuraL.J., ClinganD., RudlandP.S.Initiation of cell proliferation in cultured mouse fibroblasts by prostaglandin F2?.Proc Natl Acad Sci USA1975; 72: 2724–8.
30.
KoS.D., PageR.C., NarayananA.S.Fibroblast heterogeneity and prostaglandin regulation of subpopulations.Proc Natl Acad Sci USA1977; 74: 3429–32.
31.
KornJ.H., HalushkaP.V., LeroyE.C.Mononuclear cell modulation of connective tissue function. Suppression of fibroblast growth by stimulation of endogenous prostaglandin production.J Clin Invest1980; 65: 543–54.
32.
AliA.E., BarrettJ.C., ElingT.E.Prostaglandin and thromboxane production by fibroblasts and vascular endothelial cells.Prostaglandins1980; 20: 667–88.
33.
DurantS., DuvalD., Homo-DelarcheF.Mouse embryo fibroblasts in culture: characteristics of arachidonic acid metabolism during early passages.Prostaglandins Leukotrienes Essential Fatty Acids1988; 32: 129–37.
34.
WarwarR.E., BullockJ.D., BallalD.Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients.Ophthalmology1998; 105: 263–8.
35.
AnandN., SahniK., MenageM.J.Modification of trabeculectomy with single-dose intraoperative 5- fluorouracil application.Acta Ophthalmol Scand1998; 76: 83–9.
36.
KhawP.T., DoyleJ.W., SherwoodM.B., SmithM.F., McGorrayS.Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit.Ophthalmology1993; 100: 367–72.
